254 related articles for article (PubMed ID: 25700110)
1. Roadside drug testing: comparison of two legal approaches in Belgium.
Van der Linden T; Wille SM; Ramírez-Fernandez M; Verstraete AG; Samyn N
Forensic Sci Int; 2015 Apr; 249():148-55. PubMed ID: 25700110
[TBL] [Abstract][Full Text] [Related]
2. Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany.
Musshoff F; Hokamp EG; Bott U; Madea B
Forensic Sci Int; 2014 May; 238():120-4. PubMed ID: 24699311
[TBL] [Abstract][Full Text] [Related]
3. On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users.
Samyn N; van Haeren C
Int J Legal Med; 2000; 113(3):150-4. PubMed ID: 10876986
[TBL] [Abstract][Full Text] [Related]
4. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers.
Wille SM; Samyn N; Ramírez-Fernández Mdel M; De Boeck G
Forensic Sci Int; 2010 May; 198(1-3):2-6. PubMed ID: 19913376
[TBL] [Abstract][Full Text] [Related]
6. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.
Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL
Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072
[TBL] [Abstract][Full Text] [Related]
7. An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid.
Blencowe T; Pehrsson A; Lillsunde P; Vimpari K; Houwing S; Smink B; Mathijssen R; Van der Linden T; Legrand SA; Pil K; Verstraete A
Forensic Sci Int; 2011 May; 208(1-3):173-9. PubMed ID: 21183299
[TBL] [Abstract][Full Text] [Related]
8. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
Toennes SW; Kauert GF; Steinmeyer S; Moeller MR
Forensic Sci Int; 2005 Sep; 152(2-3):149-55. PubMed ID: 15978340
[TBL] [Abstract][Full Text] [Related]
9. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs.
Wille SM; Raes E; Lillsunde P; Gunnar T; Laloup M; Samyn N; Christophersen AS; Moeller MR; Hammer KP; Verstraete AG
Ther Drug Monit; 2009 Aug; 31(4):511-9. PubMed ID: 19571773
[TBL] [Abstract][Full Text] [Related]
10. Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France.
Willeman T; Bartolli M; Jourdil JF; Vial S; Eysseric-Guérin H; Stanke-Labesque F
Forensic Sci Int; 2023 Nov; 352():111835. PubMed ID: 37748427
[TBL] [Abstract][Full Text] [Related]
11. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
Crouch DJ; Walsh JM; Cangianelli L; Quintela O
Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
[TBL] [Abstract][Full Text] [Related]
12. New psychoactive substances in oral fluid of French and Belgian drivers in 2016.
Richeval C; Wille SMR; Nachon-Phanithavong M; Samyn N; Allorge D; Gaulier JM
Int J Drug Policy; 2018 Jul; 57():1-3. PubMed ID: 29631107
[TBL] [Abstract][Full Text] [Related]
13. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers.
Samyn N; De Boeck G; Verstraete AG
J Forensic Sci; 2002 Nov; 47(6):1380-7. PubMed ID: 12455668
[TBL] [Abstract][Full Text] [Related]
14. Drivers under the influence of drugs of abuse: quantification of cocaine and impaired driving.
Arroyo A; Sánchez M; Barberia E; Barbal M; Marrón MT; Mora A
Med Leg J; 2013; 81(Pt 3):135-43. PubMed ID: 24057314
[TBL] [Abstract][Full Text] [Related]
15. DUID: oral fluid and blood confirmation compared in Belgium.
Van der Linden T; Legrand SA; Silverans P; Verstraete AG
J Anal Toxicol; 2012 Jul; 36(6):418-21. PubMed ID: 22577111
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls.
Avcioglu G; Yilmaz G; Yalcin Sahiner S; Kozaci LD; Bal C; Yilmaz FM
Clin Biochem; 2021 Jul; 93():112-118. PubMed ID: 33882283
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of roadside urine drug screening in drivers suspected of driving under the influence of drugs (DUID).
Raes E; Verstraete AG
J Anal Toxicol; 2005 Oct; 29(7):632-6. PubMed ID: 16419392
[TBL] [Abstract][Full Text] [Related]
18. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood.
Gjerde H; Langel K; Favretto D; Verstraete AG
Forensic Sci Int; 2015 Nov; 256():42-5. PubMed ID: 26295911
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of four oral fluid devices (DDS®, Drugtest 5000®, Drugwipe 5+® and RapidSTAT®) for on-site monitoring drugged driving in comparison with UHPLC-MS/MS analysis.
Strano-Rossi S; Castrignanò E; Anzillotti L; Serpelloni G; Mollica R; Tagliaro F; Pascali JP; di Stefano D; Sgalla R; Chiarotti M
Forensic Sci Int; 2012 Sep; 221(1-3):70-6. PubMed ID: 22554872
[TBL] [Abstract][Full Text] [Related]
20. Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations.
Cone EJ; Presley L; Lehrer M; Seiter W; Smith M; Kardos KW; Fritch D; Salamone S; Niedbala RS
J Anal Toxicol; 2002; 26(8):541-6. PubMed ID: 12501910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
